Advanced neointimal growth is not associated with a low risk of in-stent thrombus - Optical coherence tomographic findings after first-generation drug-eluting stent implantation

Circulation Journal

Volumn 73, Issue 9, 2009, Pages 1627-1634

  Murakami, Daisuke ^a   Takano, Masamichi ^a   Yamamoto, Masanori ^a   Inami, Shigenobu ^a   Ohba, Takayoshi ^a   Seino, Yoshihiko ^a   Mizuno, Kyoichi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Drug eluting stents; Neointima; Optical coherence tomography; Thrombus

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERIAL WALL THICKNESS; ARTERY INTIMA PROLIFERATION; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CROSS-SECTIONAL STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; IMPLANTATION; INTERMETHOD COMPARISON; MALE; OPTICAL COHERENCE TOMOGRAPHY; PREVALENCE; QUANTITATIVE ANALYSIS; RISK FACTOR; STENT THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CELL PROLIFERATION; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; PACLITAXEL; PLATELET AGGREGATION INHIBITORS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SIROLIMUS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; TUNICA INTIMA;

EID: 69549110861     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-1166     Document Type: Article

References (23)

1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780. (Pubitemid 34586912)
2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323. (Pubitemid 37186209)
3. Stone GW, Ellis SG, Cox DA, Hermiller J, O' Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-231. (Pubitemid 38067635)
4. Camenzind E, Steg PG, Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents: A cause for concern. Circulation 2007; 115: 1440-1455. (Pubitemid 46648381)
5. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193-202. (Pubitemid 43929240)
6. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: Strut coverage as a marker of endothelialization. Circulation 2007; 115: 2435-2441.
7. Schomig A, Dibra A, Windecker S, Mehilli J, Suarez de Lezo J, Kaiser C, et al. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J Am Coll Cardiol 2007; 50: 1373-1380. (Pubitemid 47449734)
8. Prati F, Cera M, Ramazzotti V, Imola F, Giudice R, Propris SD, et al. From bench to bedside: A novel technique of acquiring OCT images. Circ J 2008; 72: 839-843. (Pubitemid 351716692)
9. Kawakita H, Tanaka A, Kitabata H, Imanishi T, Akasaka T. Safety and usefulness of non-occlusion image acquisition technique for optical coherence tomography. Circ J 2008; 72: 1536-1537.
10. Takano M, Inami S, Jang IK, Yamamoto M, Murakami D, Seimiya K, et al. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. Am J Cardiol 2007; 99: 1033-1038. (Pubitemid 46560470)
11. Matsumoto D, Shite J, Shinke T, Otake H, Tanino Y, Ogasawara D, et al. Neointimal coverage of sholimus-eluting stents at 6-month follow-up: Evaluated by optical coherence tomography. Eur Heart J 2007; 28: 961-967. (Pubitemid 47343895)
12. Takano M, Yamamoto M, Inami S, Murakami D, Seimiya K, Ohba T, et al. Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: Do uncovered struts persist? JAm Coll Cardiol 2008; 51: 968-969.
13. Takano M, Jang IK, Mizuno K. Neointimal proliferation around malapposed struts of a sirolimus-eluting stent: Optical coherence tomography findings. Eur Heart J 2006; 27: 1763. (Pubitemid 44297374)
14. MacNeill BD, Lowe HC, Takano M, Fuster V, Jang IK. Intravascular modalities for detection of vulnerable plaque: Current status. Arterioscler Thromb Vasc Biol 2003; 23: 1333-1342. (Pubitemid 36994519)
15. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2000; 36: 970-1062.
16. Awata M, Kotani J, Nanto S, Uematsu M, Morozumi T, Hori M, et al. Brachytherapy for in-stent restenosis. Circ J 2006; 70: 846-850.
17. Kume T, Akasaka T, Kawamoto T, Ogasawara Y, Watanabe N, Toyota E, et al. Assessment of coronary arterial thrombus by optical coherence tomography. Am J Cardiol 2006; 97: 1713-1717. (Pubitemid 43817856)
18. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet 2007; 369: 667-678. (Pubitemid 46281313)
19. Takano M, Yamamoto M, Xie Y, Murakami D, Inami S, Okamatsu K, et al. Serial long-term evaluation of neointimal stent coverage and thrombus after sirolimus-eluting stent implantation by use of coronary angioscopy. Heart 2007; 93: 1533-1536. (Pubitemid 350205543)
20. van Beusekom HMM, Saia F, Zindler JD, Lemos PA, Swager-Ten Hoor SL, van Leeuwen MA, et al. Drug-eluting stents show delayed healing: Paclitaxel more pronounced than sirolimus. Eur Heart J 2007; 28: 974-979. (Pubitemid 47343915)
21. Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 2005; 112: 270-278. (Pubitemid 40982311)
22. Luscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, et al. Drug-eluting stent and coronary thrombosis: Biological mechanisms and clinical implications. Circulation 2007; 115: 1051-1058. (Pubitemid 46328299)
23. Parry TJ, Brosius R, Thyagarajan R, Carter D, Argentieri D, Falotico R, et al. Drug-eluting stents: Sirolimus and paclitaxel differently affect cultured cells and injured arteries. Eur J Pharmacol 2005; 524: 19-29. (Pubitemid 41606808)